[UCI-Calit2] The Northrop Grumman Entrepreneurship Course for Scientists and Engineers

Shellie Nazarenus snaz at calit2.uci.edu
Tue Apr 10 13:44:55 PDT 2007


Date: Thursday, April 12, 2007 8:00 am - 9:20 am

Presenter: James Mazzo, Chairman, President and Chief Executive Officer
Advanced Medical Optics, Inc.

Location: McDonnell Douglas Engineering Auditorium, UCI campus

Cost: Free and open to the public 

Details: Jim Mazzo is chairman, president and chief executive officer of Advanced Medical Optics (AMO). He assumed the positions of president and CEO in 2002 as part of AMO's spin-off from Allergan, Inc. 
 
Since taking the helm of AMO, he has formed a cohesive and experienced management team, and focused the energies of more than 3,800 employees around the globe on a common mission: improving shareholder value through the discovery and delivery of innovative vision technologies that optimize quality of life for people of all ages. Mr. Mazzo has also been instrumental in several major acquisitions worth nearly $3 billion. In June of 2004, AMO finalized the acquisition of Pfizer's ophthalmic surgical business, solidifying its portfolio of intraocular lenses and enabling it to enter the glaucoma medical device market with a new product. In May of 2005, the company completed its acquisition of VISX, Incorporated for $1.27 billion. In January of 2007, AMO announced the acquisition of WaveFront Sciences and its intent to acquire IntraLase for more than $800 million.   The company's entrepreneurial spirit and success have been recognized by Wall Street, with growth in market cap of AMO going up from approximately $429 million in 2002 to more than $2 billion today. 
 
Mr. Mazzo honed his management skills during a 22-year career at Allergan, where he held a variety of executive-level positions and eventually became the company's corporate vice president and president of the ophthalmic surgical and contact lens care businesses.  Mr. Mazzo is the only executive from the ophthalmic and eye care industry to serve on the executive board of AdvaMed, the world's largest medical device organization. He serves on the University of California at Irvine (UCI) Dean's Board of Directors' Executive Committee, UCI Dean's Board of Business and Engineering, and is a trustee for Chapman University, the University of San Diego, the UCI Foundation, member of the UCI Chief Executive Roundtable, and is the only non-ophthalmologist member of the International Intraocular Implant Club (IIIC). 





More information about the UCI-Calit2 mailing list